Abstract
I read with interest the recent article by Blum et al. [1] investigating single agent clofarabine in patients with relapsed or refractory aggressive non-Hodgkin lymphoma (NHL). The study reported o...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
